38 Stocks Moving in Tuesday's Pre-Market Session

Gainers

• Koss Corporation KOSS shares rose 69% to $10.17 in pre-market trading. Koss gained around 80% on Monday as the stock gained retail investor attention on social media.
• Vertex Energy, Inc. VTNR shares rose 62% to $2.64 in pre-market trading after climbing over 27% on Monday.
• Phunware, Inc. PHUN rose 39% to $2.02 in pre-market trading. Phunware, last week, announced 2021 blockchain roadmap.
• Phio Pharmaceuticals Corp. PHIO rose 27% to $3.66 in pre-market trading as the company was awarded U.S. patent #10,900,03 'Methods for treating aging and skin disorders using nucleic acids targeting Tyr or MMP1.'
• electroCore, Inc. ECOR shares rose 21.9% to $3.34 in pre-market trading. electroCore, last week, reported Scottish Health Technology Group recommendation for use of gammaCore in cluster headache patients.
• Atossa Therapeutics, Inc. ATOS rose 19.8% to $3.57 in pre-market trading after jumping over 59% on Monday. The company’s CEO will speak Tuesday at 2:30 p.m. ET at Precision Medicine World Conference.
• GeoVax Labs, Inc. GOVX shares rose 18.6% to $6.06 in pre-market trading after gaining 11% on Monday. GeoVax, earlier during the month, announced it was awarded an NIH grant to advance its Covid-19 vaccine development.
• Athersys, Inc. ATHX rose 18.6% to $2.55 in pre-market trading after jumping over 10% on Monday.
• GSE Systems, Inc. GVP rose 18.6% to $2.49 in pre-market trading. GSE Systems recently won $8.7 million in 3 new contracts.
• Motus GI Holdings, Inc. MOTS shares rose 18.6% to $1.66 in pre-market trading after declining over 8% on Monday. Motus, earlier during the month, announced it has received approval from DEKRA for enhancements to the Pure-Vu GEN2 system.
• Property Solutions Acquisition Corp. PSAC rose 17.8% to $13.46 in pre-market trading.
• Oramed Pharmaceuticals Inc. ORMP rose 17.2% to $8.03 in pre-market trading after jumping 24% on Monday. Oramed last week said it dosed patients across multiple sites in Phase 3 oral insulin study.
• BlackBerry Limited BB shares rose 16.5% to $21.00 in pre-market trading after the company announced late Monday it has expanded its partnership with Chinese tech giant Baidu on self-driving technology.
• GameStop Corp. GME shares rose 16.6% to $89.55 in pre-market trading after surging 18% on Monday.
• Allena Pharmaceuticals, Inc. ALNA rose 16% to $1.96 in pre-market trading.
• Seanergy Maritime Holdings Corp SHIP rose 15.7% to $1.40 in pre-market trading after jumping around 23% on Monday. Seanergy Maritime, earlier during the month, announced successful completion of $179 million financial restructuring.
• LAIX Inc. LAIX rose 15% to $2.46 in pre-market trading after climbing over 20% on Monday.
• KemPharm, Inc. KMPH rose 14.6% to $8.63 in pre-market trading. KemPharm shares jumped 25% on Monday after Roth Capital initiated coverage on the stock with a Buy rating and a $28 price target.
• U.S. Well Services, Inc. USWS rose 13.1% to $1.10 in pre-market trading. U.S. Well Services shares jumped 15% on Monday after the company regained compliance with Nasdaq market value of listed securities rule.
• MBIA Inc. MBI rose 13.2% to $7.90 in pre-market trading.
• Overstock.com, Inc. OSTK shares rose 11.7% to $75.25 in pre-market trading as the company announced a partnership with Pelion Venture Partners to oversee the blockchain assets of its subsidiary Medici Ventures.
• Just Energy Group Inc. JE shares rose 10.8% to $8.44 in pre-market trading after gaining over 11% on Monday.
• TPG Pace Beneficial Finance Corp. TPGY shares rose 10.7% to $26.76 in pre-market trading after declining over 7% on Monday.
• Sunnova Energy International Inc. NOVA rose 10.2% to $54.91 in pre-market trading after dropping around 8% on Monday.
• Adamas Pharmaceuticals, Inc. ADMS shares rose 9.7% to $5.57 in pre-market trading.
• Futu Holdings LimitedFUTU rose 9.2% to $111.70 in pre-market trading.
• Ligand Pharmaceuticals Incorporated LGND rose 7.7% to $168.00 in pre-market trading. Ligand Pharmaceuticals is expected to release quarterly results on February 3.
• Nokia Corporation NOK rose 5.1% to $5.11 in pre-market trading. Nokia shares surged in part due to the efforts of r/wallstreetbets — a Reddit group with 2.1 million users — but another likely factor is a bullish report from SEB, a Swedish analyst company.
• Apollo Global Management Inc APO rose 4% to $47.66 in pre-market trading after the company announced the results of a review of CEO Leon Black's ties with Jeffrey Epstein. The review found the company never retained Epstein for services but announced Black will retire as CEO.
• Graco Inc. GGG rose 3.1% to $77.11 in pre-market trading after the company reported better-than-expected Q4 results.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

• Repro Med Systems, Inc. KRMD fell 17.3% to $4.25 in pre-market trading after the company reported weak preliminary sales for FY20 and announced the resignation of CEO and President Don Pettigrew.
• Seelos Therapeutics Inc SEEL fell 11.7% to $2.35 in pre-market trading after the company reported a common stock offering.
• Express, Inc. EXPR shares fell 10.6% to $3.71 in pre-market trading. Express shares surged around 132% on Monday amid increased interest from retail investor groups..
• Sanchez Midstream Partners LP SNMP shares fell 10.5% to $1.19 in pre-market trading after jumping around 54% on Monday.
• Lipocine Inc LPCN fell 8.6% to $2.01 in pre-market trading after the company reported a common stock offering.
• Steel Connect, Inc. STCN fell 7.6% to $2.18 in pre-market trading after declining around 5% on Monday.
• Qumu Corp QUMU fell 7.5% to $7.50 in pre-market trading after the company reported preliminary Q4 and FY20 results and announced the launch of a public offering of $20 million of common stock.
• Aurinia Pharmaceuticals Inc. AUPH shares fell 5.9% to $17.63 in pre-market trading. Aurinia Pharmaceuticals jumped 26% on Monday after the company's treatment for Active Lupus Nephritis was approved by the FDA.